Cas no 342613-67-6 (3-Bromo-7-chloroimidazo1,2-apyridine)
3-Bromo-7-chloroimidazo1,2-apyridine Chemical and Physical Properties
Names and Identifiers
-
- 3-Bromo-7-chloroimidazo[1,2-a]pyridine
- Imidazo[1,2-a]pyridine, 3-bromo-7-chloro-
- 3-bromo-7-chloro-imidazo-[1,2-a]-pyridine
- QC-4817
- 3-BROMO-7-CHLOROIMIDAZO [1,2-A]PYRIDINE
- LBPZKTZBYAXZDD-UHFFFAOYSA-N
- FCH1402820
- OR110071
- 3-Bromo-7-chloro-imidazo[1,2-a]pyridine
- AB0057239
- AX8246467
- 3-bromo-7-chloroimidazo[1,2-alpha]pyridine
- AM20051090
- V5308
- ST24041952
- SCHEMBL3030423
- DTXSID50674750
- 342613-67-6
- CS-0036470
- 3-Bromo-7-chloroimidazo[1 pound not2-a]pyridine
- SY111962
- AS-9375
- MFCD11111834
- AKOS015835755
- 3-Bromo-7-chloroimidazo1,2-apyridine
-
- MDL: MFCD11111834
- Inchi: 1S/C7H4BrClN2/c8-6-4-10-7-3-5(9)1-2-11(6)7/h1-4H
- InChI Key: LBPZKTZBYAXZDD-UHFFFAOYSA-N
- SMILES: BrC1=CN=C2C=C(C=CN21)Cl
Computed Properties
- Exact Mass: 229.92500
- Monoisotopic Mass: 229.925
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 11
- Rotatable Bond Count: 0
- Complexity: 155
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 17.3
- XLogP3: 3.4
Experimental Properties
- Color/Form: Solid
- Density: 1.845
- Refractive Index: 1.707
- PSA: 17.30000
- LogP: 2.75020
3-Bromo-7-chloroimidazo1,2-apyridine Security Information
- Signal Word:Warning
- Hazard Statement: H302;H315;H320;H335
- Warning Statement: P261;P280;P301+P312;P302+P352;P305+P351+P338
- Storage Condition:Room temperature
3-Bromo-7-chloroimidazo1,2-apyridine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| AstaTech | 52765-1/G |
3-BROMO-7-CHLOROIMIDAZO[1,2-A]PYRIDINE |
342613-67-6 | 97% | 1g |
$42 | 2023-09-17 | |
| AstaTech | 52765-5/G |
3-BROMO-7-CHLOROIMIDAZO[1,2-A]PYRIDINE |
342613-67-6 | 97% | 5g |
$116 | 2023-09-17 | |
| AstaTech | 52765-10/G |
3-BROMO-7-CHLOROIMIDAZO[1,2-A]PYRIDINE |
342613-67-6 | 97% | 10/G |
$808 | 2022-06-02 | |
| Apollo Scientific | OR110071-1g |
3-Bromo-7-chloroimidazo[1,2-a]pyridine |
342613-67-6 | 1g |
£115.00 | 2025-02-19 | ||
| TRC | B683928-100mg |
3-Bromo-7-chloroimidazo[1,2-a]pyridine |
342613-67-6 | 100mg |
$ 69.00 | 2023-04-18 | ||
| TRC | B683928-250mg |
3-Bromo-7-chloroimidazo[1,2-a]pyridine |
342613-67-6 | 250mg |
$ 138.00 | 2023-04-18 | ||
| TRC | B683928-500mg |
3-Bromo-7-chloroimidazo[1,2-a]pyridine |
342613-67-6 | 500mg |
$ 201.00 | 2023-04-18 | ||
| TRC | B683928-1g |
3-Bromo-7-chloroimidazo[1,2-a]pyridine |
342613-67-6 | 1g |
$ 287.00 | 2023-04-18 | ||
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | B845151-250mg |
3-Bromo-7-chloroimidazo[1,2-a]pyridine |
342613-67-6 | 98% | 250mg |
444.60 | 2021-05-17 | |
| Matrix Scientific | 131135-1g |
3-Bromo-7-chloroimidazo[1,2-a]pyridine |
342613-67-6 | 1g |
$135.00 | 2023-09-07 |
3-Bromo-7-chloroimidazo1,2-apyridine Related Literature
-
James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156
-
Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
-
Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
-
Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
-
Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
Additional information on 3-Bromo-7-chloroimidazo1,2-apyridine
3-Bromo-7-Chloroimidazo[1,2-a]Pyridine: A Comprehensive Overview of Structure, Synthesis, and Applications
3-Bromo-7-chloroimidazo[1,2-a]pyridine, with the chemical identifier CAS No. 342613-67-6, represents a critical compound in the field of medicinal chemistry and organic synthesis. This molecule belongs to the class of imidazo[1,2-a]pyridine derivatives, which are known for their diverse biological activities and structural versatility. Recent advancements in chemical research have highlighted the importance of 3-bromo-7-chloroimidazo[1,2-a]pyridine as a key intermediate in the development of novel pharmaceutical agents and functional materials. The unique combination of bromine and chlorine substituents on the imidazo[1,2-a]pyridine ring contributes to its distinct chemical properties, making it a focal point for both academic and industrial exploration.
The imidazo[1,2-a]pyridine ring is a heterocyclic structure that has gained significant attention due to its ability to modulate molecular interactions with biological targets. The presence of halogen atoms such as bromine and chlorine in specific positions, such as the 3- and 7-positions, enhances the compound's reactivity and selectivity. These substituents play a crucial role in determining the molecule's pharmacokinetic profile and its potential as a lead compound for drug development. Recent studies have demonstrated that the 3-bromo-7-chloroimidazo[1,2-a]pyridine scaffold can be modified to achieve desired biological activities, including antitumor, anti-inflammatory, and antimicrobial properties.
From a synthetic perspective, the preparation of 3-bromo-7-chloroimidazo[1,2-a]pyridine involves multi-step organic reactions, often requiring precise control of reaction conditions to ensure high yield and purity. One of the most promising synthetic routes involves the coupling of imidazo[1,2-a]pyridine precursors with brominated and chlorinated reagents. This approach has been extensively explored in recent years, with researchers focusing on optimizing reaction parameters such as temperature, solvent, and catalysts. For instance, a 2023 study published in Organic & Biomolecular Chemistry reported the successful synthesis of 3-bromo-7-chloroimidazo[1,2-a]pyridine using a modified Ullmann coupling method, which significantly improved the efficiency of the reaction compared to traditional protocols.
The biological relevance of 3-bromo-7-chloroimidazo[1,2-a]pyridine has been further validated by its application in drug discovery. Researchers have identified its potential as a scaffold for designing small-molecule inhibitors targeting specific enzymes and receptors. For example, a 2022 study in Journal of Medicinal Chemistry highlighted the ability of this compound to inhibit the activity of kinase enzymes, which are implicated in various pathological conditions. The 3-bromo-7-chloroimidazo[1,2-a]pyridine structure provides a flexible platform for introducing additional functional groups, enabling the fine-tuning of its biological activity. This adaptability has made it a valuable tool in the development of targeted therapies for diseases such as cancer and neurodegenerative disorders.
Beyond its pharmaceutical applications, 3-bromo-7-chloroimidazo[1,2-a]pyridine has also found relevance in materials science. The molecule's electronic properties, particularly its ability to form charge-transfer complexes, have led to its exploration as a component in organic semiconductors. A 2024 study in Advanced Materials demonstrated that 3-bromo-7-chloroimidazo[1,2-a]pyridine derivatives can be used to fabricate high-performance organic light-emitting diodes (OLEDs). The halogen substituents in the imidazo[1,2-a]pyridine ring influence the molecule's energy levels, making it suitable for applications in optoelectronics and photovoltaic devices.
Despite its promising properties, the synthesis and application of 3-bromo-7-chloroimidazo[1,2-a]pyridine present several challenges. One of the primary concerns is the potential toxicity of halogenated compounds, which requires careful evaluation of their safety profiles. Additionally, the scalability of synthetic methods for industrial production remains an area of active research. However, recent advances in green chemistry and catalytic methodologies have provided new strategies to address these challenges. For instance, the use of environmentally friendly solvents and metal-free catalysts has been explored to reduce the ecological impact of 3-bromo-7-chloroimidazo[1,2-a]pyridine synthesis.
In summary, 3-bromo-7-chloroimidazo[1,2-a]pyridine is a multifunctional compound with broad applications in medicinal chemistry, materials science, and pharmaceutical research. Its unique structure and reactivity make it a valuable candidate for the development of novel therapeutics and advanced materials. As ongoing research continues to uncover new properties and applications, the importance of this compound in scientific innovation is expected to grow further.
342613-67-6 (3-Bromo-7-chloroimidazo1,2-apyridine) Related Products
- 4926-47-0(3-Bromoimidazo[1,2-a]pyridine)
- 69214-12-6(3,5-Dibromoimidazo1,2-apyridine)
- 886371-28-4(3-Bromo-6-chloroimidazo[1,2-a]pyridine)
- 112581-95-0(2-Bromoimidazo[1,2-a]pyridine)
- 1333222-44-8(2,3-Dibromoimidazo[1,2-a]pyridine)
- 1263058-56-5(3-Bromo-8-chloroimidazo1,2-apyridine)
- 1260825-69-1(2-Bromo-7-Chloroimidazo1,2-APyridine)
- 628691-89-4(Imidazo[1,2-a]pyridine, 3-bromo-7-chloro-8-fluoro-)
- 1146615-84-0(3-Bromo-6-chloroimidazo[1,2-a]pyridine hydrobromide)
- 1072944-57-0(3,8-Dibromo-6-chloroimidazo1,2-apyridine)